Page last updated: 2024-08-25

cromakalim and eye

cromakalim has been researched along with eye in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chiang, CH; Lin, CH1
Bahler, CK; Dosa, PI; Fautsch, MP; Holman, BH; Roy Chowdhury, U1
Dosa, PI; Fautsch, MP; Roy Chowdhury, U1
Conart, JB; Trechot, F; Trechot, P1
Dosa, PI; Fautsch, MP; Holman, BH; Roy Chowdhury, U; Stoltz, KL; Viker, KB1
Bahler, CK; Dosa, PI; Fautsch, MP; Hann, CR; Holman, BH; Kudgus, RA; Reid, JM; Rinkoski, TA; Roy Chowdhury, U1
Anderson, KJ; Dosa, PI; Fautsch, MP; Holman, BH; Millar, JC; Roddy, GW; Roy Chowdhury, U1

Other Studies

7 other study(ies) available for cromakalim and eye

ArticleYear
Effects of cromakalim and nicorandil on intraocular pressure after topical administration in rabbit eyes.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1995,Fall, Volume: 11, Issue:3

    Topics: Administration, Topical; Animals; Antihypertensive Agents; Benzopyrans; Blood Flow Velocity; Chymotrypsin; Cromakalim; Eye; Female; Intraocular Pressure; Male; Niacinamide; Nicorandil; Ocular Hypertension; Ophthalmic Solutions; Potassium Channels; Pyrroles; Rabbits

1995
Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Animals; Cells, Cultured; Cromakalim; Drug Therapy, Combination; Eye; Female; Glaucoma; Humans; Intraocular Pressure; KATP Channels; Latanoprost; Male; Mice; Mice, Inbred C57BL; Middle Aged; Models, Biological; Prostaglandins F, Synthetic; Tissue Donors

2015
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
    Experimental eye research, 2019, Volume: 178

    Topics: Antihypertensive Agents; Cromakalim; Eye; KATP Channels

2019
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
    Experimental eye research, 2019, Volume: 178

    Topics: Antihypertensive Agents; Cromakalim; Eye; KATP Channels

2019
Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity.
    Journal of medicinal chemistry, 2016, 07-14, Volume: 59, Issue:13

    Topics: Animals; Antihypertensive Agents; Cromakalim; Dipeptides; Eye; Humans; Intraocular Pressure; KATP Channels; Mice, Inbred C57BL; Phosphates; Rabbits

2016
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
    PloS one, 2020, Volume: 15, Issue:4

    Topics: Administration, Intravenous; Administration, Topical; Animals; Aqueous Humor; Chromatography, Liquid; Cornea; Cromakalim; Eye; Female; Mass Spectrometry; Prodrugs; Rabbits; Vitreous Body

2020
Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models.
    Investigative ophthalmology & visual science, 2022, 02-01, Volume: 63, Issue:2

    Topics: Animals; Antihypertensive Agents; Cromakalim; Diazoxide; Disease Models, Animal; Eye; Intraocular Pressure; KATP Channels; Mice; Mice, Inbred DBA; Microscopy, Electron, Transmission; Ocular Hypertension; Ophthalmic Solutions

2022